Efficacy of JAK STAT Pathways Inhibitors in Treatment of Patients With Rheumatoid Arthritis

NANot yet recruitingINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

July 31, 2023

Primary Completion Date

July 31, 2025

Study Completion Date

December 31, 2025

Conditions
Rheumatoid Arthritis
Interventions
DIETARY_SUPPLEMENT

"apigenin and glycyrrhizin"

"apigenin will be administered as capsule (10mg,eq 200mg Matricaria chamomilla L extract) two times daily. Also, glycyrrhizin will be administered as capsule(50 mg eq 250 mg licorice extract) two times daily. The two types of capsules administration will be continue for 6 months"

DIETARY_SUPPLEMENT

"glycyrrhizin and boswellic acid"

"boswellic acid will be administered as capsule (200mg,eq 250mg Boswellia serrata extract) two times daily. Also, glycyrrhizin will be administered as capsule(50 mg eq 250 mg licorice extract) two times daily. The two types of capsules administration will be continue for 6 months"

DIETARY_SUPPLEMENT

"placebo"

"Placebo capsule will be administered two times daily for 6 months"

All Listed Sponsors
lead

Adel A.Gomaa

OTHER

NCT05788705 - Efficacy of JAK STAT Pathways Inhibitors in Treatment of Patients With Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter